These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 3362350)

  • 41. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY; Mogenson GJ
    J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
    Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area.
    Shi WX; Zhang XY; Pun CL; Bunney BS
    Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.
    Schad CA; Justice JB; Holtzman SG
    J Pharmacol Exp Ther; 2002 Mar; 300(3):932-8. PubMed ID: 11861800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of methamphetamine on dopamine cells in the substantia nigra pars compacta and the ventral tegmental area.
    Kamata K; Kameyama T
    Jpn J Pharmacol; 1985 Jun; 38(2):231-4. PubMed ID: 4032860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.
    French ED; Dillon K; Wu X
    Neuroreport; 1997 Feb; 8(3):649-52. PubMed ID: 9106740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphine-induced activation of A10 dopamine neurons in the rat.
    Gysling K; Wang RY
    Brain Res; 1983 Oct; 277(1):119-27. PubMed ID: 6315137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area.
    Olpe HR; Koella WP; Wolf P; Haas HL
    Brain Res; 1977 Oct; 134(3):577-80. PubMed ID: 902118
    [No Abstract]   [Full Text] [Related]  

  • 50. Activity of dopamine-containing substantia nigra neurons in freely moving cats.
    Trulson ME
    Neurosci Biobehav Rev; 1985; 9(2):283-97. PubMed ID: 3925396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.
    Shi WX; Pun CL; Zhang XX; Jones MD; Bunney BS
    J Neurosci; 2000 May; 20(9):3504-11. PubMed ID: 10777813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of neurons in the ventral tegmental region of the behaving monkey.
    Fabre M; Rolls ET; Ashton JP; Williams G
    Behav Brain Res; 1983 Aug; 9(2):213-35. PubMed ID: 6309194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors.
    Di Giovanni G; Di Matteo V; La Grutta V; Esposito E
    Neuroscience; 2001; 103(1):111-6. PubMed ID: 11311791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insomnia following hypocretin2-saporin lesions of the substantia nigra.
    Gerashchenko D; Blanco-Centurion CA; Miller JD; Shiromani PJ
    Neuroscience; 2006; 137(1):29-36. PubMed ID: 16289583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat.
    Joyce EM; Iversen SD
    Neurosci Lett; 1979 Oct; 14(2-3):207-12. PubMed ID: 530497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y; Ashby CR; Schwartz JE; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):143-50. PubMed ID: 1665793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.